Introduction：Basic information about CAS 1262036-50-9|LY2886721, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | LY2886721 |
|---|
| CAS Number | 1262036-50-9 | Molecular Weight | 390.407 |
|---|
| Density | 1.6±0.1 g/cm3 | Boiling Point | / |
|---|
| Molecular Formula | C18H16F2N4O2S | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
| Name | N-[3-[(4aS,7aS)-2-amino-4,4a,5,7-tetrahydrofuro[3,4-d][1,3]thiazin-7a-yl]-4-fluorophenyl]-5-fluoropyridine-2-carboxamide |
|---|
| Synonym | More Synonyms |
|---|
LY2886721 BiologicalActivity
| Description | LY2886721 is an BACE inhibitor used for the treatment of Alzheimer's Disease.IC50 value:Target: BACELY2886721 is a novel potent agent that is used to treat Alzheimer’s Disease in preclinical experiments. LY2886721 is under clinical study. A Safety Study of LY2886721 Multiple Doses is performing in Healthy Subjects. |
|---|
| Related Catalog | Signaling Pathways >>Neuronal Signaling >>Beta-secretaseResearch Areas >>Neurological Disease |
|---|
| References | [1]. A Safety Study of LY2886721 Multiple Doses in Healthy Subjects |
|---|
Chemical & Physical Properties
| Density | 1.6±0.1 g/cm3 |
|---|
| Molecular Formula | C18H16F2N4O2S |
|---|
| Molecular Weight | 390.407 |
|---|
| Exact Mass | 390.096191 |
|---|
| PSA | 112.40000 |
|---|
| LogP | 0.80 |
|---|
| Index of Refraction | 1.706 |
|---|
| InChIKey | NIDRNVHMMDAAIK-YPMLDQLKSA-N |
|---|
| SMILES | NC1=NC2(c3cc(NC(=O)c4ccc(F)cn4)ccc3F)COCC2CS1 |
|---|
| Storage condition | -20°C |
|---|
Safety Information
Synonyms
| LY-2886721 |
| cc-426 |
| S2156_Selleck |
| UNII:2CQ62IWB67 |
| LY2886721 |
| UNII-2CQ62IWB67 |
| LY 2886721 |
